FASTBASE Solution SL 

Breakthrough assay to predict patient response to immunotherapy

OWNER

Fernando Aguirre (See Profile)

Sector

Diagnostics

Stage

Prototyping, preclinical

Country

Spain


A patented molecular diagnostics platform with a <10nm resolution in histopathology

Unprecedentely accurate quantification of protein complexes in tumour samples

It quantifies PD-1/PD-L1 engaged complexes for an accurate and unique prediction of patient response to immune therapy

This information is confidential, do not share or copy.

Under evaluation at least till: 27th March

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar